Clinical Trial Update: Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections. [Phase 4]

View source ↗

Summary

Phase 4 randomized, placebo-controlled, double-blind study of 2LHERP for orofacial herpes infections is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infection

Drugs mentioned

• 2LHERP

Snippet

Sponsor: Labo'Life | Conditions: Herpes Simplex | Phase 4 | Status: RECRUITING